Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything

Nature Reviews Urology, Published online: 02 August 2022; doi:10.1038/s41585-022-00634-wMuscle-invasive bladder cancer (MIBC) remains a deadly disease, despite aggressive surgical and systemic chemotherapeutic treatments. New treatment modalities are needed. A novel intravesicle drug delivery device for neoadjuvant treatment of MIBC has been developed, and preliminary results on the efficacy and safety of this system are available.

https://www.nature.com/articles/s41585-022-00634-w

Source: Nature Reviews Urology - August 2, 2022 Category: Urology & Nephrology Authors: Katherine M. Rodriguez Max Kates Source Type: research